Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 149

    1.

    "Orphan drugs" for the Third World.

    Simon HJ.

    Ann Intern Med. 1981 Aug;95(2):231-2. No abstract available. PMID: 7258877 [PubMed - indexed for MEDLINE]Related articles

    2.

    Pharmaceuticals for developing countries: an interface of science, technology, and public policy.

    Simon HJ.

    Pharos Alpha Omega Alpha Honor Med Soc. 1981 Spring;44(2):9-15. No abstract available. PMID: 7243857 [PubMed - indexed for MEDLINE]Related articles

    3.

    Orphan drugs: creating a policy.

    Asbury CH, Stolley PD.

    Ann Intern Med. 1981 Aug;95(2):221-4.PMID: 7258873 [PubMed - indexed for MEDLINE]Related articles

    4.

    Economics of essential drugs schemes: the perspectives of the developing countries.

    Wang'ombe JK, Mwabu GM.

    Soc Sci Med. 1987;25(6):625-30.PMID: 3686097 [PubMed - indexed for MEDLINE]Related articles

    5.

    TRIPS, pharmaceutical patents, and access to essential medicines: a long way from Seattle to Doha.

    't Hoen E.

    Chic J Int Law. 2002 Spring;3(1):27-46. No abstract available. PMID: 15709298 [PubMed - indexed for MEDLINE]Related articles

    6.

    Pharmaceuticals and the developing world.

    Kremer M.

    J Econ Perspect. 2002 Fall;16(4):67-90. No abstract available. PMID: 15179979 [PubMed - indexed for MEDLINE]Related articles

    7.

    Orphan drugs and orphan diseases: clinical realities and public policy. Proceedings of a conference, Ann Arbor, Michigan, September 27-29, 1982.

    [No authors listed]

    Prog Clin Biol Res. 1983;127:1-263. No abstract available. PMID: 6889397 [PubMed - indexed for MEDLINE]Related articles

    8.

    World Health Assembly:

    Turner J.

    Lancet. 1984 May 26;1(8387):1172-3.PMID: 11644284 [PubMed - indexed for MEDLINE]Related articles

    9.

    Bangladesh national drug policy: an example for the Third World?

    Islam N.

    Trop Doct. 1999 Apr;29(2):78-80.PMID: 10418296 [PubMed - indexed for MEDLINE]Related articles

    10.

    The economics of essential drug programmes.

    Smith GT.

    Soc Sci Med. 1987;25(6):621-4.PMID: 3686096 [PubMed - indexed for MEDLINE]Related articles

    11.

    Patent immorality?

    Bloche MG, Jungman ER.

    Am J Bioeth. 2002 Summer;2(3):48-9. No abstract available. PMID: 12230859 [PubMed - indexed for MEDLINE]Related articles

    12.

    EU agrees deal on cheaper drugs for developing world.

    Watson R.

    BMJ. 2003 Jun 7;326(7401):1229. No abstract available. PMID: 12791716 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Orphan drugs.

    Davies DM.

    Lancet. 1983 Feb 5;1(8319):290-1.PMID: 11644251 [PubMed - indexed for MEDLINE]Related articles

    14.

    US policy may encourage counterfeit drugs.

    Bouchie A.

    Nat Biotechnol. 2003 Feb;21(2):121. No abstract available. PMID: 12560826 [PubMed - indexed for MEDLINE]Related articles

    15.

    When medicine becomes a disease.

    [No authors listed]

    Arabia. 1986 Mar;5(55):32-6.PMID: 12340711 [PubMed - indexed for MEDLINE]Related articles

    16.

    Sparks fly over patents and vital drugs at world health assembly.

    Kapp C.

    Lancet. 2003 May 31;361(9372):1873. No abstract available. PMID: 12788578 [PubMed - indexed for MEDLINE]Related articles

    17.

    Economic and policy implications of reimportation: a Canadian perspective.

    Ward C.

    Manag Care. 2004 Mar;13(3 Suppl):17-20. No abstract available. PMID: 15074165 [PubMed - indexed for MEDLINE]Related articles

    18.

    Not taking, just borrowing: government use of patented drugs.

    Ossorio PN.

    Am J Bioeth. 2002 Summer;2(3):51-2. No abstract available. PMID: 12230861 [PubMed - indexed for MEDLINE]Related articles

    19.

    Companies to cut cost of AIDS drugs for poor nations.

    McNeil DG Jr.

    NY Times (Print). 2000 May 12:A1,4. No abstract available. PMID: 11873792 [PubMed - indexed for MEDLINE]Related articles

    20.

    TRIPS, pharmaceuticals, developing countries, and the Doha "solution".

    Sykes AO.

    Chic J Int Law. 2002 Spring;3(1):47-68. No abstract available. PMID: 15709299 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data